Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Mvasi. Always confirm against the full prescribing information.
100 interactions
Alendronic acid
The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Bevacizumab is combined with Alendronic acid.
Level 2 evidence
Anastrozole
The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Anastrozole.
Level 2 evidence
Arsenic trioxide
The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Arsenic trioxide.
Level 2 evidence
Articaine
The risk or severity of methemoglobinemia can be increased when Bevacizumab is combined with Articaine.
Level 1 evidence
Benzocaine
The risk or severity of methemoglobinemia can be increased when Bevacizumab is combined with Benzocaine.
Level 1 evidence
Benzyl alcohol
The risk or severity of methemoglobinemia can be increased when Bevacizumab is combined with Benzyl alcohol.
Level 1 evidence
Bleomycin
The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Bleomycin.
Level 2 evidence
Bortezomib
The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Bortezomib.
Level 2 evidence
Bupivacaine
The risk or severity of methemoglobinemia can be increased when Bevacizumab is combined with Bupivacaine.
Level 1 evidence
Busulfan
The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Busulfan.
Level 2 evidence
Butamben
The risk or severity of methemoglobinemia can be increased when Bevacizumab is combined with Butamben.
Level 1 evidence
Cabazitaxel
The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Cabazitaxel.
Mvasi (Bevacizumab-Awwb) has 231 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Mvasi (Bevacizumab-Awwb) has 1 major, 70 moderate, and 160 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Mvasi. Always confirm against the full prescribing information.